Underwriter |
Biotechnology |
Date |
Offering |
6/30/05 |
Offering |
After-Market |
| ||||||
Adams Harkness |
Martek Biosciences Corp. (MATK) (co-lead) |
1/21/05 |
$49.10 |
$37.96 |
$86.3 |
-23% |
A.G. Edwards |
Favrille Inc. (FVRL) (IPO) |
2/2/05 |
$7 |
$4.25 |
$42 |
-39% |
Banc of America |
Amylin Pharmaceuticals Inc. (AMLN) |
1/21/05 |
$22 |
$20.93 |
$202.4 |
-5% |
|
Aspreva Pharmaceuticals Corp. (ASPV) (IPO; co-lead) |
3/3/05 |
$11 |
$15.49 |
$91.1 |
+41% |
|
ISTA Pharmaceuticals Inc. (ISTA) (co-lead) |
1/20/05 |
$8.88 |
$8.32 |
$56.2 |
-6% |
|
Threshold Pharmaceuticals Inc. (THLD) (IPO; co-lead) |
2/4/05 |
$7 |
$8.25 |
$37.3 |
+18% |
Bear, Stearns |
Favrille Inc. (FVRL) (IPO; lead) |
2/2/05 |
$7 |
$4.25 |
$42 |
-39% |
BMO Nesbitt |
Aspreva Pharmaceuticals Corp. (ASPV) (IPO) |
3/3/05 |
$11 |
$15.49 |
$91.1 |
+41% |
|
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$10.05 |
$61.2 |
-34% |
C.E. Unterberg, |
ISTA Pharmaceuticals Inc. (ISTA) |
1/20/05 |
$8.88 |
$8.32 |
$56.2 |
-6% |
CIBC World |
Arena Pharmaceuticals Inc. (ARNA) (co-lead) |
2/1/05 |
$6 |
$6.82 |
$51.75 |
+14% |
|
Bioenvision Inc. (BIVN) |
2/3/05 |
$8 |
$7.28 |
$60 |
-9% |
|
Cardiome Pharma Corp. (CRME) (co-lead) |
3/18/05 |
$6 |
$5.29 |
$58.65 |
-12% |
|
CoTherix Inc. (CTRX) (co-lead) |
2/10/05 |
$8.90 |
$10.19 |
$37.83 |
+14% |
|
Favrille Inc. (FVRL) (IPO) |
2/2/05 |
$7 |
$4.25 |
$42 |
-39% |
|
Icagen Inc. (ICGN) (IPO) |
2/3/05 |
$8 |
$7.85 |
$40.8 |
-2% |
|
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$10.05 |
$61.2 |
-34% |
|
Nuvelo Inc. (NUVO) |
2/2/05 |
$7.50 |
$7.73 |
$73.31 |
+3% |
|
Progenics Pharmaceuticals Inc. (PGNX) (co-lead) |
4/1/05 |
$15.25 |
$20.86 |
$30.5 |
+37% |
|
SeraCare Life Sciences Inc. (SRLS) (lead) |
5/25/05 |
$12.25 |
$13.99 |
$42.6 |
+14% |
|
Threshold Pharmaceuticals Inc. (THLD) (IPO; co-lead) |
2/4/05 |
$7 |
$8.25 |
$37.3 |
+18% |
Citigroup |
Martek Biosciences Corp. (MATK) (co-lead) |
1/21/05 |
$49.10 |
$37.96 |
$86.3 |
-23% |
Credit Suisse |
ViaCell Inc. (VIAC) (IPO; co-lead) |
1/21/05 |
$7 |
$10.65 |
$60.38 |
+52% |
D.A. Davidson |
Martek Biosciences Corp. (MATK) |
1/21/05 |
$49.10 |
$37.96 |
$86.3 |
-23% |
Desjardins |
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$10.05 |
$61.2 |
-34% |
Deutsche Bank |
Nuvelo Inc. (NUVO) (co-lead) |
2/2/05 |
$7.50 |
$7.73 |
$73.31 |
+3% |
|
XenoPort Inc. (XNPT) (IPO; co-lead) |
6/2/05 |
$10.50 |
$12.79 |
$52.5 |
+22% |
First Albany |
CV Therapeutics Inc. (CVTX) |
6/29/05 |
$21.60 |
$22.42 |
$180.4 |
+4% |
|
Martek Biosciences Corp. (MATK) |
1/21/05 |
$49.10 |
$37.96 |
$86.3 |
-23% |
First Associates |
Cardiome Pharma Corp. (CRME) |
3/18/05 |
$6 |
$5.29 |
$58.65 |
-12% |
First Dunbar |
CardioVascular BioTherapeutics Inc. (OTC BB:CVBT) (IPO; lead) |
3/14/05 |
$10 |
$7.60 |
$17.25 |
-24% |
Friedman, Billings, |
Bioenvision Inc. (BIVN) |
2/3/05 |
$8 |
$7.28 |
$60 |
-9% |
|
Tercica Inc. (TRCA) |
2/8/05 |
$8 |
$8.69 |
$55.2 |
+9% |
Fortis Securities |
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$10.05 |
$61.2 |
-34% |
GMP Securities |
Cardiome Pharma Corp. (CRME) |
3/18/05 |
$6 |
$5.29 |
$58.65 |
-12% |
Goldman, Sachs |
Amylin Pharmaceuticals Inc. (AMLN) (co-lead) |
1/21/05 |
$22 |
$20.93 |
$202.4 |
-5% |
Granite Financial |
Arena Pharmaceuticals Inc. (ARNA) |
2/1/05 |
$6 |
$6.82 |
$51.75 |
+14% |
Harris Nesbitt |
Northfield Laboratories Inc. (NFLD) |
2/4/05 |
$15 |
$14.31 |
$77.63 |
-5% |
|
Tercica Inc. (TRCA) |
2/8/05 |
$8 |
$8.69 |
$55.2 |
+9% |
Jefferies & Co. |
Neose Technologies Inc. (NTEC) |
2/18/05 |
$4 |
$3.15 |
$32.2 |
-21% |
JP Morgan |
Amylin Pharmaceuticals Inc. (AMLN) |
1/21/05 |
$22 |
$20.93 |
$202.4 |
-5% |
|
Barrier Therapeutics Inc. (BTRX) |
2/10/05 |
$19.50 |
$7.93 |
$39 |
-59% |
|
Bioenvision Inc. (BIVN) (co-lead) |
2/3/05 |
$8 |
$7.28 |
$60 |
-9% |
|
Icagen Inc. (ICGN) (IPO; co-lead) |
2/3/05 |
$8 |
$7.85 |
$40.8 |
-2% |
|
Neose Technologies Inc. (NTEC) |
2/18/05 |
$4 |
$3.15 |
$32.2 |
-21% |
|
Telik Inc. (TELK) |
1/28/05 |
$18.75 |
$16.25 |
$151 |
-13% |
|
Vertex Pharmaceuticals Inc. (VRTX) |
6/7/05 |
$13 |
$16.33 |
$175.6 |
+26% |
Lazard Freres |
ISTA Pharmaceuticals Inc. (ISTA) |
1/20/05 |
$8.88 |
$8.32 |
$56.2 |
-6% |
|
Threshold Pharmaceuticals Inc. (THLD) (IPO) |
2/4/05 |
$7 |
$8.25 |
$37.3 |
+18% |
|
ViaCell Inc. (VIAC) (IPO) |
1/21/05 |
$7 |
$10.65 |
$60.38 |
+52% |
|
XenoPort Inc. (XNPT) (IPO) |
6/2/05 |
$10.50 |
$12.79 |
$52.5 |
+22% |
Leerink Swann |
Cardiome Pharma Corp. (CRME) |
3/18/05 |
$6 |
$5.29 |
$58.65 |
-12% |
|
ViaCell Inc. (VIAC) (IPO) |
1/21/05 |
$7 |
$10.65 |
$60.38 |
+52% |
Lehman Brothers |
CV Therapeutics Inc. (CVTX) (co-lead) |
6/29/05 |
$21.60 |
$22.42 |
$180.4 |
+4% |
|
Telik Inc. (TELK) |
1/28/05 |
$18.75 |
$16.25 |
$151 |
-13% |
|
Tercica Inc. (TRCA) (co-lead) |
2/8/05 |
$8 |
$8.69 |
$55.2 |
+9% |
Merrill Lynch |
Aspreva Pharmaceuticals Corp. (ASPV) (IPO; co-lead) |
3/3/05 |
$11 |
$15.49 |
$91.1 |
+41% |
|
CV Therapeutics Inc. (CVTX) (co-lead) |
6/29/05 |
$21.60 |
$22.42 |
$180.4 |
+4% |
|
Vertex Pharmaceuticals Inc. (VRTX) (lead) |
6/7/05 |
$13 |
$16.33 |
$175.6 |
+26% |
Morgan Stanley |
Amylin Pharmaceuticals Inc. (AMLN) (co-lead) |
1/21/05 |
$22 |
$20.93 |
$202.4 |
-5% |
|
Barrier Therapeutics Inc. (BTRX) (lead) |
2/10/05 |
$19.50 |
$7.93 |
$39 |
-59% |
|
XenoPort Inc. (XNPT) (IPO; co-lead) |
6/2/05 |
$10.50 |
$12.79 |
$52.5 |
+22% |
Morgan Joseph |
Arena Pharmaceuticals Inc. (ARNA) |
2/1/05 |
$6 |
$6.82 |
$51.75 |
+14% |
Needham & Co. |
Arena Pharmaceuticals Inc. (ARNA) |
2/1/05 |
$6 |
$6.82 |
$51.75 |
+14% |
|
CoTherix Inc. (CTRX) |
2/10/05 |
$8.90 |
$10.19 |
$37.83 |
+14% |
|
Favrille Inc. (FVRL) (IPO) |
2/2/05 |
$7 |
$4.25 |
$42 |
-39% |
|
Martek Biosciences Corp. (MATK) |
1/21/05 |
$49.10 |
$37.96 |
$86.3 |
-23% |
|
Nuvelo Inc. (NUVO) |
2/2/05 |
$7.50 |
$7.73 |
$73.31 |
+3% |
Orion Securities |
Cardiome Pharma Corp. (CRME) |
3/18/05 |
$6 |
$5.29 |
$58.65 |
-12% |
Pacific |
Aspreva Pharmaceuticals Corp. (ASPV) (IPO) |
3/3/05 |
$11 |
$15.49 |
$91.1 |
+41% |
|
Barrier Therapeutics Inc. (BTRX) |
2/10/05 |
$19.50 |
$7.93 |
$39 |
-59% |
|
La Jolla Pharmaceutlcal Co. (LJPC) (lead) |
1/28/05 |
$1.40 |
$0.80 |
$17.2 |
-43% |
|
XenoPort Inc. (XNPT) (IPO) |
6/2/05 |
$10.50 |
$12.79 |
$52.5 |
+22% |
Piper Jaffray |
Arena Pharmaceuticals Inc. (ARNA) (co-lead) |
2/1/05 |
$6 |
$6.82 |
$51.75 |
+14% |
|
CoTherix Inc. (CTRX) |
2/10/05 |
$8.90 |
$10.19 |
$37.83 |
+14% |
|
CV Therapeutics Inc. (CVTX) |
6/29/05 |
$21.60 |
$22.42 |
$180.4 |
+4% |
|
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$10.05 |
$61.2 |
-34% |
Punk, Ziegel |
Zonagen Inc. (ZONA) (co-lead) |
1/27/05 |
$4 |
$3.83 |
$20.2 |
-4% |
Robert W. Baird |
Tercica Inc. (TRCA) |
2/8/05 |
$8 |
$8.69 |
$55.2 |
+9% |
SG Cowen & Co. |
CV Therapeutics Inc. (CVTX) |
6/29/05 |
$21.60 |
$22.42 |
$180.4 |
+4% |
|
Northfield Laboratories Inc. (NFLD) (co-lead) |
2/4/05 |
$15 |
$14.31 |
$77.63 |
-5% |
|
Tercica Inc. (TRCA) (co-lead) |
2/8/05 |
$8 |
$8.69 |
$55.2 |
+9% |
|
Vivus Inc. (VVUS) (co-lead) |
3/10/05 |
$3.40 |
$3.69 |
$21.25 |
+9% |
Thomas Weisel |
CoTherix Inc. (CTRX) |
2/10/05 |
$8.90 |
$10.19 |
$37.83 |
+14% |
|
ISTA Pharmaceuticals Inc. (ISTA) (co-lead) |
1/20/05 |
$8.88 |
$8.32 |
$56.2 |
-6% |
|
SeraCare Life Sciences Inc. (SRLS) |
5/25/05 |
$12.25 |
$13.99 |
$42.6 |
+14% |
UBS Investment |
Bioenvision Inc. (BIVN) (co-lead) |
2/3/05 |
$8 |
$7.28 |
$60 |
-9% |
|
Cardiome Pharma Corp. (CRME) (co-lead) |
3/18/05 |
$6 |
$5.29 |
$58.65 |
-12% |
|
Icagen Inc. (ICGN) (IPO; co-lead) |
2/3/05 |
$8 |
$7.85 |
$40.8 |
-2% |
|
Neose Technologies Inc. (NTEC) (lead) |
2/18/05 |
$4 |
$3.15 |
$32.20 |
-21% |
|
Neurochem Inc. (NRMX) (lead) |
3/4/05 |
$15.30 |
$10.05 |
$61.20 |
-34% |
|
Northfield Laboratories Inc. (NFLD) (co-lead) |
2/4/05 |
$15 |
$14.31 |
$77.63 |
-5% |
|
Nuvelo Inc. (NUVO) (co-lead) |
2/2/05 |
$7.50 |
$7.73 |
$73.31 |
+3% |
|
Progenics Pharmaceuticals Inc. (PGNX) (lead) |
6/10/05 |
$19.25 |
$20.86 |
$29.50 |
+8% |
|
Progenics Pharmaceuticals Inc. (PGNX) (co-lead) |
4/1/05 |
$15.25 |
$20.86 |
$30.50 |
+37% |
|
Telik Inc. (TELK) (lead) |
1/28/05 |
$18.75 |
$16.25 |
$151 |
-13% |
|
Vertex Pharmaceuticals Inc. (VRTX) |
6/7/05 |
$13 |
$16.33 |
$175.6 |
+26% |
|
ViaCell Inc. (VIAC) (IPO; co-lead) |
1/21/05 |
$7 |
$10.65 |
$60.38 |
+52% |
Wachovia Capital |
Amylin Pharmaceuticals Inc. (AMLN) |
1/21/05 |
$22 |
$20.93 |
$202.4 |
-5% |
|
Vivus Inc. (VVUS) (co-lead) |
3/10/05 |
$3.40 |
$3.69 |
$21.25 |
+9% |
Wells Fargo |
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$10.05 |
$61.2 |
-34% |
William Blair |
SeraCare Life Sciences Inc. (SRLS) |
5/25/05 |
$12.25 |
$13.99 |
$42.6 |
+14% |
|
Threshold Pharmaceuticals Inc. (THLD) (IPO) |
2/4/05 |
$7 |
$8.25 |
$37.3 |
+18% |
WR Hambrecht |
Zonagen Inc. (ZONA) (co-lead) |
1/27/05 |
$4 |
$3.83 |
$20.2 |
-4% |
| ||||||
Notes: | ||||||
* The financings in this chart include only public offerings of stock in the U.S. The data were compiled primarily from BioWorld Financial Watch's monthly financing charts covering the period from Jan. 1 to June 30, 2005. The gross proceed totals include money raised through overallotment options, when applicable. | ||||||
Unless otherwise noted, shares are traded on the Nasdaq exchange. | ||||||
OTC BB = Over-the-Counter Bulletin Board. |